• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有酒精ism家族易感性的个体中N-甲基-D-天冬氨酸谷氨酸受体拮抗剂反应的改变。

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.

作者信息

Petrakis Ismene L, Limoncelli Diana, Gueorguieva Ralitza, Jatlow Peter, Boutros Nashaat N, Trevisan Louis, Gelernter Joel, Krystal John H

机构信息

West Haven VA Medical Center (116-A), 950 Campbell Ave., West Haven, CT 06516, USA.

出版信息

Am J Psychiatry. 2004 Oct;161(10):1776-82. doi: 10.1176/ajp.161.10.1776.

DOI:10.1176/ajp.161.10.1776
PMID:15465973
Abstract

OBJECTIVE

A family history of alcoholism is a risk factor for the development of ethanol dependence. Ethanol is an antagonist of the N-methyl-d-aspartate (NMDA) glutamate receptor, and alterations in NMDA receptor function are thought to be involved in ethanol abuse and dependence. The purpose of this study was to determine in healthy individuals with no ethanol dependence whether response to the NMDA receptor antagonist ketamine would differentiate those with a family history of ethanol dependence from those without such a family history.

METHOD

Healthy subjects between the ages of 21 and 30 received 40-minute intravenous infusions of saline, low-dose ketamine (0.1 mg/kg), and high-dose ketamine (0.5 mg/kg) on three separate test days in a randomized order under double-blind conditions. The healthy individuals with at least one first-degree relative and another first- or second-degree relative with ethanol dependence (N=16) were compared with those who had no family history of ethanol dependence in any first- or second-degree relative (N=29). Outcome measures included the Brief Psychiatric Rating Scale, Clinician-Administered Dissociative States Scale, verbal fluency, Hopkins Verbal Learning Test, a biphasic alcohol effects scale, visual analog scales of mood states, and ketamine levels.

RESULTS

During ketamine infusion, individuals with a family history of ethanol dependence showed an attenuated response in terms of perceptual alterations and dysphoric mood relative to those without such a family history.

CONCLUSIONS

These data suggest that alterations in NMDA receptor function may contribute to subjective response to ethanol and therefore also to the risk of developing alcoholism.

摘要

目的

酗酒家族史是乙醇依赖发展的一个风险因素。乙醇是N-甲基-D-天冬氨酸(NMDA)谷氨酸受体的拮抗剂,NMDA受体功能的改变被认为与乙醇滥用和依赖有关。本研究的目的是确定在无乙醇依赖的健康个体中,对NMDA受体拮抗剂氯胺酮的反应是否能区分有乙醇依赖家族史的个体和无此类家族史的个体。

方法

21至30岁的健康受试者在双盲条件下,于三个不同的测试日以随机顺序接受40分钟的静脉输注生理盐水、低剂量氯胺酮(0.1mg/kg)和高剂量氯胺酮(0.5mg/kg)。将至少有一个一级亲属以及另一个一级或二级亲属有乙醇依赖的健康个体(N = 16)与在任何一级或二级亲属中均无乙醇依赖家族史的个体(N = 29)进行比较。结果测量包括简明精神病评定量表、临床医生实施的分离状态量表、语言流畅性、霍普金斯语言学习测试、双相酒精效应量表、情绪状态视觉模拟量表和氯胺酮水平。

结果

在氯胺酮输注期间,有乙醇依赖家族史的个体相对于无此类家族史的个体,在知觉改变和烦躁情绪方面表现出减弱的反应。

结论

这些数据表明,NMDA受体功能的改变可能导致对乙醇的主观反应,因此也可能导致酗酒风险。

相似文献

1
Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.有酒精ism家族易感性的个体中N-甲基-D-天冬氨酸谷氨酸受体拮抗剂反应的改变。
Am J Psychiatry. 2004 Oct;161(10):1776-82. doi: 10.1176/ajp.161.10.1776.
2
Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients.恢复中的酒精依赖患者对NMDA谷氨酸受体拮抗剂的反应改变。
Neuropsychopharmacology. 2003 Nov;28(11):2020-8. doi: 10.1038/sj.npp.1300252.
3
Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism.纳曲酮增强低剂量氯胺酮的作用:对酒精中毒药物治疗的潜在意义。
Neuropsychopharmacology. 2006 Aug;31(8):1793-800. doi: 10.1038/sj.npp.1300994. Epub 2006 Jan 4.
4
Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics.N-甲基-D-天冬氨酸受体拮抗剂氯胺酮对近期戒酒的酗酒者的剂量相关乙醇样效应。
Arch Gen Psychiatry. 1998 Apr;55(4):354-60. doi: 10.1001/archpsyc.55.4.354.
5
NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy.N-甲基-D-天冬氨酸受体拮抗作用与乙醇中毒信号:从酒精中毒风险到药物治疗
Ann N Y Acad Sci. 2003 Nov;1003:176-84. doi: 10.1196/annals.1300.010.
6
Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist.酒精依赖家族史与对N-甲基-D-天冬氨酸拮抗剂的初始抗抑郁反应
Biol Psychiatry. 2009 Jan 15;65(2):181-4. doi: 10.1016/j.biopsych.2008.09.029. Epub 2008 Nov 8.
7
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.拉莫三嗪减轻氯胺酮的神经精神效应:支持N-甲基-D-天冬氨酸受体拮抗剂的高谷氨酸能效应
Arch Gen Psychiatry. 2000 Mar;57(3):270-6. doi: 10.1001/archpsyc.57.3.270.
8
Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists.尼莫地平预处理对恢复酒精依赖男性氯胺酮效应的减弱作用:NMDA与L型钙通道拮抗剂相互作用的精神药理学意义
Neuropsychopharmacology. 2001 Dec;25(6):936-47. doi: 10.1016/S0893-133X(01)00346-3.
9
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.非竞争性N-甲基-D-天冬氨酸(NMDA)拮抗剂氯胺酮对人体的亚麻醉作用。拟精神病性、感知、认知及神经内分泌反应。
Arch Gen Psychiatry. 1994 Mar;51(3):199-214. doi: 10.1001/archpsyc.1994.03950030035004.
10
Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.双相抑郁中 N-甲基-D-天冬氨酸拮抗剂的家族性酒精依赖与抗抑郁反应。
Bipolar Disord. 2012 Dec;14(8):880-7. doi: 10.1111/bdi.12003. Epub 2012 Sep 14.

引用本文的文献

1
Acute Subjective Experiences of Intravenous Ketamine Therapy Among Medically Hospitalized Patients with Alcohol Use Disorder.酒精使用障碍住院患者静脉注射氯胺酮治疗的急性主观体验
Psychedelic Med (New Rochelle). 2024 Jun 17;2(2):116-126. doi: 10.1089/psymed.2023.0066. eCollection 2024 Jun.
2
Effects of Chronic Social Isolation Stress and Alcohol on the Reinforcing Properties of Ketamine in Male and Female Rats.慢性社会隔离应激和酒精对雄性和雌性大鼠氯胺酮强化特性的影响。
eNeuro. 2025 Mar 3;12(3). doi: 10.1523/ENEURO.0452-24.2025. Print 2025 Mar.
3
Modeling Brain Gene Expression in Alcohol Use Disorder with Genetic Animal Models.
利用遗传动物模型模拟酒精使用障碍中的脑基因表达
Curr Top Behav Neurosci. 2023 Nov 21. doi: 10.1007/7854_2023_455.
4
Ketamine-New Possibilities in the Treatment of Depression: A Narrative Review.氯胺酮——抑郁症治疗中的新可能:一篇叙述性综述
Life (Basel). 2021 Nov 5;11(11):1186. doi: 10.3390/life11111186.
5
On the Use of Heterogeneous Stock Mice to Map Transcriptomes Associated With Excessive Ethanol Consumption.关于使用异种品系小鼠绘制与过量乙醇摄入相关的转录组图谱
Front Psychiatry. 2021 Oct 12;12:725819. doi: 10.3389/fpsyt.2021.725819. eCollection 2021.
6
Effect of ketamine on binge drinking patterns in crossed high alcohol-preferring (cHAP) mice.氯胺酮对酒精偏爱交叉高(cHAP)小鼠 binge 饮酒模式的影响。
Alcohol. 2021 Dec;97:31-39. doi: 10.1016/j.alcohol.2021.09.004. Epub 2021 Sep 20.
7
Effects of the Fyn kinase inhibitor saracatinib on ventral striatal activity during performance of an fMRI monetary incentive delay task in individuals family history positive or negative for alcohol use disorder. A pilot randomised trial.Fyn激酶抑制剂萨拉卡替尼对酒精使用障碍家族史阳性或阴性个体在功能磁共振成像金钱激励延迟任务执行期间腹侧纹状体活动的影响。一项初步随机试验。
Neuropsychopharmacology. 2022 Mar;47(4):840-846. doi: 10.1038/s41386-021-01157-5. Epub 2021 Sep 2.
8
Rewarding Subjective Effects of the NMDAR Antagonist Nitrous Oxide (Laughing Gas) Are Moderated by Impulsivity and Depressive Symptoms in Healthy Volunteers.健康志愿者的冲动性和抑郁症状可调节 NMDA 受体拮抗剂一氧化二氮(笑气)的主观效应。
Int J Neuropsychopharmacol. 2021 Jul 23;24(7):551-561. doi: 10.1093/ijnp/pyab009.
9
Neural Mechanisms Underlying the Rewarding and Therapeutic Effects of Ketamine as a Treatment for Alcohol Use Disorder.氯胺酮治疗酒精使用障碍的奖赏和治疗作用的神经机制
Front Behav Neurosci. 2020 Dec 10;14:593860. doi: 10.3389/fnbeh.2020.593860. eCollection 2020.
10
Neurobiological biomarkers of response to ketamine.氯胺酮反应的神经生物学生物标志物。
Adv Pharmacol. 2020;89:195-235. doi: 10.1016/bs.apha.2020.05.003. Epub 2020 Jun 18.